1 From the Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
A live varicella vaccine was developed in 1973 and has been used effectively and safely in normal as well as high-risk children. Some precautions are necessary for use in the high-risk children.
This article has been cited by other articles:
![]() |
V. N. Loparev, K. McCaustland, B. P. Holloway, P. R. Krause, M. Takayama, and D. S. Schmid Rapid Genotyping of Varicella-Zoster Virus Vaccine and Wild-Type Strains with Fluorophore-Labeled Hybridization Probes J. Clin. Microbiol., December 1, 2000; 38(12): 4315 - 4319. [Abstract] [Full Text] |
||||
![]() |
V. N. Loparev, T. Argaw, P. R. Krause, M. Takayama, and D. S. Schmid Improved Identification and Differentiation of Varicella-Zoster Virus (VZV) Wild-Type Strains and an Attenuated Varicella Vaccine Strain Using a VZV Open Reading Frame 62-Based PCR J. Clin. Microbiol., September 1, 2000; 38(9): 3156 - 3160. [Abstract] [Full Text] |
||||
![]() |
C. Grose Varicella-Zoster Virus: Less Immutable Than Once Thought Pediatrics, May 1, 1999; 103(5): 1027 - 1028. [Full Text] |
||||